- Software-as-a-service and ancillary solutions provider IMEXHS (IME) has entered a trading halt ahead of an upcoming capital raise
- At this stage, it’s unclear just how much IME wants to raise and what it’ll put the funding towards
- As a result, IME shares will be paused until Thursday, October 22, or when more details are released to the market
- Second waves of COVID-19 in key markets have led to a relative reduction in the number of images, which has impacted overall revenue for the company
- On the ASX, IME last traded for 3 cents per share on October 19
Software-as-a-service and ancillary solutions provider IMEXHS (IME) has entered a trading halt ahead of an upcoming capital raise.
At this stage, it’s unclear just how much IME wants to raise and what it’ll put the funding towards.
Company shares will be in a halt until Thursday, October 22, or when more details about the capital raise is released to the market.
IME offers flexible and scalable imaging solutions to hospitals and clinics. The solutions help medical imaging companies manage, store, distribute, view and help analyse images like patient scans.
Yesterday, IME released its third-quarter activity report, which saw the company table $6.7 million in year-to-date revenue — up 21 per cent on the previous corresponding period.
However, the company’s quarterly recurring revenue was down 1 per cent on a constant currency basis, and down 16 per cent compared to this time last year due to the impact of COVID-19 on IME’s trading volumes. Speaking to the results, IMEXHS says the resurgence of COVID-19 in some of its key markets had impacted the company’s revenue.
IME closed the quarter with $3.8 million in the bank after it repaid its $1 million loan to private company Domatorisaro.
On the ASX, IME last traded for 3 cents per share on October 19.